Status:
NOT_YET_RECRUITING
Repletion of Ergothioneine in Patients With Kidney Failure
Lead Sponsor:
Stanford University
Conditions:
Esrd
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Dialysis removes potentially harmful chemicals from the blood but can also remove potentially valuable chemicals. One potentially valuable chemical called ergothioneine, which comes from our diet, is ...
Eligibility Criteria
Inclusion
- kidney failure receiving hemodialysis or peritoneal dialysis
Exclusion
- blood transfusion within 90 days
- taking supplements which contain ergothioneine
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06487546
Start Date
October 1 2024
End Date
October 1 2027
Last Update
July 5 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.